HomeOrderingContact UsAbout UsInvestor InformationSite Map

 

TRANSGENOMIC is a global biotechnology company that provides unique products and services for automated high sensitivity genetic variation and mutation analysis. Our offering includes systems, products, discovery and laboratory testing services to the academic and medical research, clinical laboratory and pharmaceutical markets in the fields of pharmacogenomics and personalized medicine.
 

  WAVE® Systems and Consumables
  SURVEYOR® Mutation Detection Products
  Cytogenetics Automated Systems
  Transgenomic Labs
  Pharmacogenomic Services
   

TRANSGENOMIC technologies are highlighted in more than 1,800 peer-reviewed journal articles.


ISO 9001
FM 538914

ISO 9001:2008 Certification Transgenomic instrument and consumable product manufacturing, distribution and instrument support services at the Irvington, NE, USA facility has received ISO Certification of Registration for Quality Management.

 

 

 

 

 
What's New
Listen Webcast Alert Reminder - Transgenomic CEO Craig Tuttle will be presenting at the Maxim Conference
Mar 26 - Jun 1
Listen Webcast Alert Reminder - Transgenomic Inc. Reports First Quarter 2012 Results
May 7 - Jul 8
Abstract - Somatic mosaicism in a patient with Lynch syndrome
Abstract - Development of a denaturing high-performance liquid chromatography method for detection of protist parasites of metazoans
Abstract - Rapid identification of mitochondrial DNA (mtDNA) mutations in neuromuscular disorders by using surveyor strategy
May 8 Press Releases
Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today
May 8 Press Releases
Transgenomic Reports First Quarter 2012 Financial Results
May 1 Press Releases
Transgenomic to Hold First Quarter Financial Results Conference Call on May 8, 2012
 
Contact WebmasterSend Page To ColleaguePrintable PageChange Country United States
Copyright © 1997-2012 Transgenomic, Inc., All Rights Reserved.the power of discovery™